Can You Get ADHD Medication Through Telehealth in Arizona? (2026 Rules)

Yes, for now. As of October 16, 2026, a temporary federal rule allows a DEA-registered clinician to prescribe Schedule II to V controlled medications, which include ADHD stimulants, through a live audio-video visit without having seen you in person first. That rule runs through December 31, 2026 (Federal Register (opens in a new tab)). Whether any medication is right for you is still a clinical decision made after a full evaluation.

Can you get ADHD medication through telehealth in 2026?

A federal law from 2008, the Ryan Haight Act, generally requires at least one in-person medical evaluation before a clinician prescribes a controlled substance remotely. Once a clinician has done one in-person evaluation of a patient, that specific requirement no longer applies to that clinician and patient (Federal Register (opens in a new tab)).

During the COVID-19 public health emergency, the DEA made temporary exceptions so clinicians could prescribe by video. Those “telemedicine flexibilities” were extended in 2023, again in 2023, in 2024, and most recently in a fourth extension published December 31, 2025. The fourth extension is effective January 1 through December 31, 2026 (DEA (opens in a new tab)). Under it, a prescription issued without an in-person exam must meet all of these conditions (Federal Register (opens in a new tab)):

• It is issued for a legitimate medical purpose, in the usual course of the clinician’s practice.
• It follows a live visit using an interactive telecommunications system. For Schedule II stimulants that means audio and video, not a phone call alone.
• The clinician’s DEA registration covers that class of medication.
• It meets every other federal prescription rule, and state law too.

HHS confirms the extension runs through December 31, 2026 (Telehealth.HHS.gov (opens in a new tab)). None of this means a stimulant will be prescribed. It only removes the in-person requirement while the extension lasts.

What happens to the DEA telehealth rules after December 31, 2026?

On January 17, 2025, the DEA proposed a permanent framework called a Special Registration for Telemedicine. It would let registered clinicians prescribe controlled substances by audio-video visit without a prior in-person exam, with added prescription, recordkeeping and reporting requirements (Federal Register (opens in a new tab)). The fourth extension says it gives the DEA time to finish permanent rules. As of October 16, 2026, no final special registration rule had been published in the Federal Register.

The DEA describes the risk of the flexibilities simply ending as a “telemedicine cliff”: the return of the pre-pandemic in-person requirement (Federal Register (opens in a new tab)). Before the end of 2026, the DEA could finalize a permanent rule, extend the flexibilities again, or do neither.

Which ADHD medications are controlled substances?

Federal rules list amphetamine, methylphenidate and lisdexamfetamine as Schedule II stimulants (eCFR, 21 CFR 1308.12 (opens in a new tab)). That covers products such as Adderall and Ritalin. Schedule II prescriptions cannot be refilled. A clinician may instead issue several prescriptions at once, totaling up to a 90-day supply, with dates before which each one cannot be filled. The rule says clearly that this is the prescriber’s judgment, not a requirement (eCFR, 21 CFR 1306.12 (opens in a new tab)).

Prescription stimulants carry an FDA boxed warning about abuse, misuse and addiction. The label tells prescribers to assess each patient’s risk before prescribing, to teach patients about safe storage and disposal, and to reassess throughout treatment (FDA label, Adderall XR (opens in a new tab)). That is part of why stimulant care involves regular follow-up.

Stimulants are the most common ADHD medication, and NIMH notes that non-stimulant medications are also used (NIMH (opens in a new tab)). Some non-stimulants are not controlled substances at all, so the DEA telemedicine rule does not apply to them. The FDA labels say so for atomoxetine (Strattera label, DailyMed (opens in a new tab)) and for guanfacine extended-release (FDA label, Intuniv (opens in a new tab)). The ADHD evaluation guide covers the non-stimulant options and their warnings in more detail. Do not start, stop or change any medication on your own.

Video · 10:24 · Mayo ClinicAdult ADHD: Mayo Clinic Radio

Who can prescribe ADHD medication in Arizona?

Physicians can, and so can nurse practitioners and physician assistants who meet Arizona’s requirements. Under Arizona Board of Nursing rules, a nurse practitioner needs Board authority to prescribe and a DEA registration before prescribing controlled substances. With both, a nurse practitioner may prescribe Schedule II medications, may not prescribe refills of them, and must follow all other legal limits (Arizona Administrative Code, R4-19-511 and R4-19-512 (opens in a new tab)). The same rules say a nurse practitioner must have examined the patient and established a professional relationship before prescribing, with narrow exceptions.

Physician assistants in Arizona need board approval and their own DEA registration to prescribe Schedule II or III controlled substances (A.R.S. 32-2532 (opens in a new tab)). At Better Place Now, care is with Dr. Justin Schwarting, DNP, PMHNP-BC, a board-certified psychiatric-mental health nurse practitioner. The article on psychiatric nurse practitioners and psychiatrists explains how the roles compare.

What does Arizona law add to the federal rules?

The Arizona details come from state law. A Schedule II prescription may hold only one drug, cannot be refilled, and cannot be dispensed more than 90 days after it was issued. Only Schedule II opioids must be prescribed electronically (A.R.S. 36-2525 (opens in a new tab)). Arizona’s Controlled Substances Prescription Monitoring Program requires a pharmacist to pull a 12-month report on the patient before dispensing a Schedule II drug. The prescriber’s legal duty to check covers opioids and benzodiazepines (A.R.S. 36-2606 (opens in a new tab)). Pharmacies report every Schedule II to V prescription they dispense to the program (A.R.S. 36-2608 (opens in a new tab)).

What to expect if you are prescribed ADHD medication by telehealth in Arizona

1. 01

   Step 1: A full evaluation comes first

   At Better Place Now, the first visit is a full 60 minutes with rating scales and a detailed history. Controlled medications are prescribed only when clinically appropriate after a complete evaluation, generally not at the first visit. See the ADHD evaluation page.

2. 02

   Step 2: A prescription monitoring check

   Arizona’s monitoring program shows controlled prescriptions filled in the state. Better Place Now checks it before every controlled prescription, and the pharmacist checks it again before dispensing a Schedule II drug.

3. 03

   Step 3: The prescription goes to the pharmacy

   Each Schedule II prescription covers one drug, with no refills, and must be filled within 90 days of the date it was written. Arizona allows stimulant prescriptions to be electronic or signed and written.

4. 04

   Step 4: Pickup, and a call ahead if supply is tight

   Several stimulant products were still listed in shortage in October 2026. If your pharmacy does not have it, tell your prescriber rather than changing the medication or dose yourself.

5. 05

   Step 5: Follow-ups and a new prescription each time

   Because Schedule II drugs cannot be refilled, each supply needs a new prescription. At Better Place Now, follow-ups are 30 minutes by video, refill requests go in at least 72 hours before you run out, early refills are not provided, and a follow-up is needed if it has been more than three months since your last visit.

Better Place Now also prescribes one controlled medication at a time, and periodic lab work or an in-person evaluation may be required. These points come from the practice’s ADHD treatment page, which also explains non-stimulant choices.

Is there still an ADHD medication shortage in 2026?

Yes, for some products. On October 15, 2026, the FDA’s drug shortage database listed mixed amphetamine salts tablets (the generic form of Adderall), lisdexamfetamine capsules and chewable tablets, and methylphenidate extended-release tablets and extended-release film as currently in shortage (FDA Drug Shortages (opens in a new tab)). A listing does not mean no pharmacy has it, and it can change week to week.

If a medication is hard to find, talk to your prescriber about options rather than switching or splitting doses on your own.

How to talk to a prescriber about ADHD medication by video

• Be in Arizona for the visit. Better Place Now video visits require you to be physically in Arizona at the time.
• Bring your history: prior diagnoses, records, and every medication and supplement you take.
• Ask about the plan for 2027, and about non-stimulants, since the federal rule is temporary.
• Set up a quiet, private space with a reliable connection. The telehealth guide has more tips.

Prices and plans are on the ADHD evaluation page: most patients use insurance, and self-pay is $220 for the 60-minute evaluation. When you are ready, you can request an appointment. Most replies come within one business day, and no health details are needed to schedule.